Mounjaro is a brand-name medication. It contains the active ingredient tirzepatide. (An active ingredient is what makes a drug work.) A generic version of the drug isn’t currently available.

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

A generic version containing the same active ... Its active ingredient is tirzepatide, which is both a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a GLP-1 receptor ...

GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...

On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...